Literature DB >> 18026711

[Nasopharyngeal carcinoma. A model for modern radio-oncology].

M W Münter1, E M Stoiber, A D Jensen, J Debus.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18026711     DOI： 10.1007/s00106-007-1622-9

Source DB:  PubMed          Journal:  HNO        ISSN： 0017-6192            Impact factor:   1.284


× No keyword cloud information.
  13 in total

1.  Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma.

Authors:  Anthony T C Chan; S F Leung; Roger K C Ngan; Peter M L Teo; W H Lau; W H Kwan; Edwin P Hui; H Y Yiu; Winnie Yeo; F Y Cheung; K H Yu; K W Chiu; D T Chan; Tony S K Mok; Stephen Yau; K T Yuen; Frankie K F Mo; Maria M P Lai; Brigette B Y Ma; Michael K M Kam; Thomas W T Leung; Philip J Johnson; Peter H K Choi; Benny C Y Zee
Journal:  J Natl Cancer Inst       Date:  2005-04-06       Impact factor: 13.506

2.  Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.

Authors:  Volker Budach; Martin Stuschke; Wilfried Budach; Michael Baumann; Dirk Geismar; Gerhard Grabenbauer; Ingrid Lammert; Klaus Jahnke; Georg Stueben; Thomas Herrmann; Michael Bamberg; Peter Wust; Wolfgang Hinkelbein; Klaus-Dieter Wernecke
Journal:  J Clin Oncol       Date:  2005-02-20       Impact factor: 44.544

3.  Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.

Authors:  Marc W Münter; Simone Hoffner; Holger Hof; Klaus K Herfarth; Uwe Haberkorn; Volker Rudat; Peter Huber; Jürgen Debus; Christian P Karger
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-15       Impact factor: 7.038

4.  Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

Authors:  M Al-Sarraf; M LeBlanc; P G Giri; K K Fu; J Cooper; T Vuong; A A Forastiere; G Adams; W A Sakr; D E Schuller; J F Ensley
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

5.  Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety.

Authors:  Joseph Wee; Eng Huat Tan; Bee Choo Tai; Hwee Bee Wong; Swan Swan Leong; Terence Tan; Eu Tiong Chua; Edward Yang; Khai Mun Lee; Kam Weng Fong; Hoon Seng Khoo Tan; Kim Shang Lee; Susan Loong; Vijay Sethi; Eu Jin Chua; David Machin
Journal:  J Clin Oncol       Date:  2005-09-20       Impact factor: 44.544

6.  Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience.

Authors:  Suzanne L Wolden; William C Chen; David G Pfister; Dennis H Kraus; Sean L Berry; Michael J Zelefsky
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-02       Impact factor: 7.038

Review 7.  Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.

Authors:  Jean Bourhis; Jens Overgaard; Hélène Audry; Kian K Ang; Michele Saunders; Jacques Bernier; Jean-Claude Horiot; Aurélie Le Maître; Thomas F Pajak; Michael G Poulsen; Brian O'Sullivan; Werner Dobrowsky; Andrzej Hliniak; Krzysztof Skladowski; John H Hay; Luiz H J Pinto; Carlo Fallai; Karen K Fu; Richard Sylvester; Jean-Pierre Pignon
Journal:  Lancet       Date:  2006-09-02       Impact factor: 79.321

8.  Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival.

Authors:  Jin-Ching Lin; Jian-Sheng Jan; Chen-Yi Hsu; Wen-Miin Liang; Rong-San Jiang; Wen-Yi Wang
Journal:  J Clin Oncol       Date:  2003-02-15       Impact factor: 44.544

9.  Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.

Authors:  Marc W Münter; Christian P Karger; Simone G Hoffner; Holger Hof; Christoph Thilmann; Volker Rudat; Simeon Nill; Michael Wannenmacher; Jürgen Debus
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-01-01       Impact factor: 7.038

10.  Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation.

Authors:  Nancy Lee; Ping Xia; Nancy J Fischbein; Pam Akazawa; Clayton Akazawa; Jeanne M Quivey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-09-01       Impact factor: 7.038
View more
  1 in total

1.  [Treatment results of nasopharyngeal carcinoma in adults].

Authors:  M Jakob; M Manz; S Herberhold; A Schröck; A O H Gerstner; H Schüller; K W G Eichhorn
Journal:  HNO       Date:  2012-12       Impact factor: 1.284
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.